Clovis Oncology Inc (NASDAQ:CLVS)

48.63
Delayed Data
As of May 25
 +1.11 / +2.34%
Today’s Change
41.72
Today|||52-Week Range
99.45
-28.49%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Domain Associates Llc
Director
Sale8/04/201718,450$78.61$1.5M-38.05%
Rolfe Lindsey
Corporate Officer
Sale12/20/20176,910$63.80$440.9K-21.03%
Spickschen Thorlef
Director
Sale1/08/20184,500$64.97$292.4K-22.79%
Spickschen Thorlef
Director
Sale3/08/20184,500$61.47$276.6K-21.13%
Ivers Read Gillian C
Corporate Officer
Sale7/17/20173,000$91.56$274.7K-45.28%
Spickschen Thorlef
Director
Sale12/08/20174,500$60.00$270.0K-21.75%
Spickschen Thorlef
Director
Sale2/22/20184,500$60.00$270.0K-18.79%
Ivers Read Gillian C
Corporate Officer
Sale10/16/20173,000$84.54$253.6K-42.50%
Ivers Read Gillian C
Corporate Officer
Sale12/20/20173,512$63.80$224.1K-21.03%
Ivers Read Gillian C
Corporate Officer
Sale8/15/20173,000$70.05$210.2K-32.35%
Page of 5